- Home
- COCH vs DRIO Comparison
COCH vs DRIO Comparison
Compare COCH & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- DRIO
- Stock Information
- Founded
- COCH 1995
- DRIO 2011
- Country
- COCH United States
- DRIO United States
- Employees
- COCH N/A
- DRIO N/A
- Industry
- COCH Blank Checks
- DRIO Medical/Dental Instruments
- Sector
- COCH Finance
- DRIO Health Care
- Exchange
- COCH Nasdaq
- DRIO Nasdaq
- Market Cap
- COCH 31.6M
- DRIO 30.5M
- IPO Year
- COCH N/A
- DRIO N/A
- Fundamental
- Price
- COCH $1.62
- DRIO $0.72
- Analyst Decision
- COCH Strong Buy
- DRIO Strong Buy
- Analyst Count
- COCH 2
- DRIO 2
- Target Price
- COCH $9.25
- DRIO $2.50
- AVG Volume (30 Days)
- COCH 28.0K
- DRIO 138.1K
- Earning Date
- COCH 08-11-2025
- DRIO 08-07-2025
- Dividend Yield
- COCH N/A
- DRIO N/A
- EPS Growth
- COCH N/A
- DRIO N/A
- EPS
- COCH N/A
- DRIO N/A
- Revenue
- COCH $212,000.00
- DRIO $28,034,000.00
- Revenue This Year
- COCH $5.93
- DRIO $20.85
- Revenue Next Year
- COCH $17.69
- DRIO $17.09
- P/E Ratio
- COCH N/A
- DRIO N/A
- Revenue Growth
- COCH N/A
- DRIO 47.20
- 52 Week Low
- COCH $1.21
- DRIO $0.50
- 52 Week High
- COCH $3.99
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- COCH 58.84
- DRIO 52.15
- Support Level
- COCH $1.43
- DRIO $0.68
- Resistance Level
- COCH $1.59
- DRIO $0.74
- Average True Range (ATR)
- COCH 0.12
- DRIO 0.03
- MACD
- COCH 0.02
- DRIO 0.00
- Stochastic Oscillator
- COCH 55.00
- DRIO 57.14
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.